BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22725618)

  • 1. Pregabalin in clinical psychiatry and addiction: pros and cons.
    Martinotti G
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1243-5. PubMed ID: 22725618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of pregabalin in alcohol dependence.
    Martinotti G; Di Nicola M; Tedeschi D; Mazza M; Janiri L; Bria P
    Adv Ther; 2008 Jun; 25(6):608-18. PubMed ID: 18553183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.
    Martinotti G; Di Nicola M; Tedeschi D; Andreoli S; Reina D; Pomponi M; Mazza M; Romanelli R; Moroni N; De Filippis R; Di Giannantonio M; Pozzi G; Bria P; Janiri L
    J Psychopharmacol; 2010 Sep; 24(9):1367-74. PubMed ID: 19346279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
    Joshi I; Taylor CP
    Eur J Pharmacol; 2006 Dec; 553(1-3):82-8. PubMed ID: 17064682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregabalin in the treatment of alcohol and benzodiazepines dependence.
    Oulis P; Konstantakopoulos G
    CNS Neurosci Ther; 2010; 16(1):45-50. PubMed ID: 20070788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin for the discontinuation of long-term benzodiazepines use: an assessment of its effectiveness in daily clinical practice.
    Bobes J; Rubio G; Terán A; Cervera G; López-Gómez V; Vilardaga I; Pérez M
    Eur Psychiatry; 2012 May; 27(4):301-7. PubMed ID: 21334859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsants as anxiolytics, part 2: Pregabalin and gabapentin as alpha(2)delta ligands at voltage-gated calcium channels.
    Stahl SM
    J Clin Psychiatry; 2004 Apr; 65(4):460-1. PubMed ID: 15119905
    [No Abstract]   [Full Text] [Related]  

  • 9. Pregabalin in the discontinuation of long-term benzodiazepines' use.
    Oulis P; Konstantakopoulos G; Kouzoupis AV; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kontoangelos KA; Papadimitriou GN
    Hum Psychopharmacol; 2008 Jun; 23(4):337-40. PubMed ID: 18348245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregabalin in benzodiazepine withdrawal.
    Biermann T; Bleich S; Kornhuber J; Hillemacher T
    Pharmacopsychiatry; 2007 Nov; 40(6):292-3. PubMed ID: 18030656
    [No Abstract]   [Full Text] [Related]  

  • 11. The potential of pregabalin in neurology, psychiatry and addiction: a qualitative overview.
    Martinotti G; Lupi M; Sarchione F; Santacroce R; Salone A; De Berardis D; Serroni N; Cavuto M; Signorelli M; Aguglia E; Valchera A; Iasevoli F; Di Giannantonio M
    Curr Pharm Des; 2013; 19(35):6367-74. PubMed ID: 23782139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation with pregabalin in schizophrenia.
    Englisch S; Esser A; Enning F; Hohmann S; Schanz H; Zink M
    J Clin Psychopharmacol; 2010 Aug; 30(4):437-40. PubMed ID: 20531222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
    Taylor CP; Angelotti T; Fauman E
    Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregabalin abuse after past substance-seeking behavior.
    Papazisis G; Garyfallos G; Sardeli C; Kouvelas D
    Int J Clin Pharmacol Ther; 2013 May; 51(5):441-2. PubMed ID: 23547854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin: in the treatment of generalised anxiety disorder.
    Frampton JE; Foster RH
    CNS Drugs; 2006; 20(8):685-93; discussion 694-5. PubMed ID: 16863276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin: From molecule to medicine.
    Kavoussi R
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine.
    Prescrire Int; 2007 Jun; 16(89):104. PubMed ID: 17582925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin pharmacology and its relevance to clinical practice.
    Ben-Menachem E
    Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.